Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

81. Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials using a direct oral anticoagulant

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials using a direct oral anticoagulant Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

82. Radiofrequency ablation versus cryoablation for treating patients with paroxysmal atrial fibrillation: an overview of systematic reviews

Radiofrequency ablation versus cryoablation for treating patients with paroxysmal atrial fibrillation: an overview of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

83. Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis

Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

84. Preoperative risk prediction models for atrial fibrillation after cardiac surgery: a systematic review and retrospective external validation

Preoperative risk prediction models for atrial fibrillation after cardiac surgery: a systematic review and retrospective external validation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

85. Epidemiology of atrial fibrillation in patients undergoing bariatric surgery

Epidemiology of atrial fibrillation in patients undergoing bariatric surgery Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

86. Hemorrhagic risk in patients treated with aspirin vs. non-vitamin-K oral anticoagulants at doses approved for atrial fibrillation: systematic review and meta-analysis of randomized controlled trials

Hemorrhagic risk in patients treated with aspirin vs. non-vitamin-K oral anticoagulants at doses approved for atrial fibrillation: systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

87. Efficacy and safety of His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure

Efficacy and safety of His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

88. Extent of atrial fibrosis by late gadolinium enhancement as a predictor of successful catheter ablation of atrial fibrillation: a systematic review and meta-analysis

Extent of atrial fibrosis by late gadolinium enhancement as a predictor of successful catheter ablation of atrial fibrillation: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

89. Physical activity and atrial fibrillation: pitfalls and limitations. Insights from an umbrella review

Physical activity and atrial fibrillation: pitfalls and limitations. Insights from an umbrella review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

90. Adherence to oral anticoagulants for treatment of atrial fibrillation in the Middle East: a systematic review

Adherence to oral anticoagulants for treatment of atrial fibrillation in the Middle East: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

91. Dose-response analysis of body mass index and atrial fibrillation in patients undergoing cardiac operation

Dose-response analysis of body mass index and atrial fibrillation in patients undergoing cardiac operation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

92. Comparative efficacy of antiarrhythmic drugs and catheter ablation for maintaining sinus rhythm in patients with atrial fibrillation: a systematic review and network meta-analysis

Comparative efficacy of antiarrhythmic drugs and catheter ablation for maintaining sinus rhythm in patients with atrial fibrillation: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

93. What is the most clinical and cost effective treatment strategy (rate or rhythm control or no treatment) for people with atrial fibrillation after cardiothoracic surgery?

What is the most clinical and cost effective treatment strategy (rate or rhythm control or no treatment) for people with atrial fibrillation after cardiothoracic surgery? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

94. Meta-analysis of minimally interrupted non-vitamin K oral anticoagulants versus uninterrupted use of non-vitamin K oral anticoagulants in atrial fibrillation catheter ablation

Meta-analysis of minimally interrupted non-vitamin K oral anticoagulants versus uninterrupted use of non-vitamin K oral anticoagulants in atrial fibrillation catheter ablation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

95. Dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: an updated systematic review and meta-analysis of randomized clinical trials

Dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: an updated systematic review and meta-analysis of randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

96. Is non-transfemoral transcatheter aortic valve replacement approach associated with a higher risk of new-onset atrial fibrillation? A systematic review and meta-analysis

Is non-transfemoral transcatheter aortic valve replacement approach associated with a higher risk of new-onset atrial fibrillation? A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

97. Percutaneous closure of patent foramen ovale and its implication in the development of new-onset atrial fibrillation

Percutaneous closure of patent foramen ovale and its implication in the development of new-onset atrial fibrillation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

98. MicroRNA expression signatures in atrial fibrillation: a systematic review and bioinformatics analysis

MicroRNA expression signatures in atrial fibrillation: a systematic review and bioinformatics analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

99. Metoprolol vs Diltiazem for atrial fibrillation

Metoprolol vs Diltiazem for atrial fibrillation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

100. Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients

Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO